Disclosure: WIIP is our brand. NMN Boost is mentioned in this article as a product we selected and developed. It is evaluated alongside the same evidence applied to NMN supplementation in general.
This article is for informational purposes only and does not constitute medical advice. NMN supplements do not treat, cure, or prevent any disease. Consult your healthcare provider before starting any new supplement.
NMN Dosage — How Much Should You Actually Take?
Based on clinical trial data, 250–500mg daily is the most commonly studied and well-tolerated NMN dose for adults. The landmark Yi et al. (2023) multicentre trial tested 300mg, 600mg, and 900mg daily over 60 days and found that 600mg produced optimal NAD+ increases with no additional benefit at 900mg (Yi et al., 2023) [VERIFIED]. Australia's TGA has set the maximum recommended daily dose at 500mg per day (NutraIngredients, Dec 2025) [VERIFIED]. If you are starting NMN for the first time, 250mg daily for the first two to four weeks — then 500mg — is a reasonable, evidence-aligned approach.
What Clinical Trials Tell Us About NMN Dosage
NMN dosage recommendations should come from published human data, not marketing claims. Here is what the most rigorous trials have found, organised by dose.
Yi et al. (2023) — 300mg, 600mg, 900mg
This randomised, multicentre, double-blind, placebo-controlled trial enrolled 80 healthy middle-aged adults (40–65 years) and assigned them to placebo, 300mg, 600mg, or 900mg NMN daily for 60 days. All three NMN groups showed significant increases in blood NAD+ concentration. The 600mg and 900mg groups showed NAD+ levels that were statistically indistinguishable from each other, but significantly higher than the 300mg group. The 600mg and 900mg groups also walked significantly further in the six-minute walk test than the 300mg group, suggesting a threshold effect around 500–600mg (Yi et al., 2023) [VERIFIED].
Key takeaway: 600mg per day was the optimal dose in this trial. Going higher to 900mg did not produce measurably better results.
Kim et al. (2022) — 250mg
This randomised, double-blind, placebo-controlled study gave 108 older Japanese adults (65+ years) 250mg NMN daily for 12 weeks. The NMN group showed improved lower limb function (five-times sit-to-stand test, effect size d = 0.72 in the afternoon dosing group) and reduced daytime drowsiness (effect size d = 0.64). No adverse events were reported (Kim et al., 2022) [VERIFIED].
Key takeaway: Even 250mg daily produced measurable functional improvements in older adults over 12 weeks.
Igarashi et al. (2022) — 250mg
A 12-week placebo-controlled trial in healthy older men found that 250mg NMN daily elevated blood NAD+ levels and improved gait speed compared to placebo. The improvements were detectable at both 6 and 12 weeks (Igarashi et al., 2022) [VERIFIED].
Fukamizu et al. (2022) — 1,250mg (Safety Study)
This safety-focused trial gave 31 healthy adults (20–65 years) 1,250mg NMN daily for four weeks. No serious adverse events occurred. No clinically significant changes were found in liver enzymes, kidney function, blood chemistry, or body composition (Fukamizu et al., 2022) [VERIFIED].
Key takeaway: 1,250mg daily was safe for four weeks, but this was a safety study — it does not mean 1,250mg is the ideal dose or that it produces better outcomes than 500mg.
Dosage Summary Table
| Study | Dose | Duration | Participants | Key Finding |
|---|---|---|---|---|
| Kim et al., 2022 | 250mg | 12 weeks | 108 (ages 65+) | Improved lower limb function, reduced drowsiness |
| Igarashi et al., 2022 | 250mg | 12 weeks | 42 (older men) | Elevated NAD+, improved gait speed |
| Fukamizu et al., 2022 | 1,250mg | 4 weeks | 31 (ages 20–65) | Safe and well-tolerated at high dose |
Starting Dose vs Maintenance Dose
If you have never taken NMN before, starting at the maximum dose is unnecessary and makes it harder to assess your individual response.
Weeks 1–4: Start at 250mg Per Day
A 250mg starting dose is supported by multiple 12-week trials (Kim 2022, Igarashi 2022) that showed measurable benefits at this level [VERIFIED]. Starting low serves two purposes: it lets you confirm tolerability before increasing, and it establishes a baseline so you can actually notice whether a higher dose makes a meaningful difference.
Take one capsule (250mg) daily, preferably in the morning. Track your energy, sleep quality, and any digestive response during this period.
Week 5 Onwards: Move to 500mg Per Day
After four weeks at 250mg, increase to 500mg daily if you are tolerating the supplement well. This aligns with:
- The dose range shown effective in Yi et al. (2023) [VERIFIED]
- Australia's TGA maximum recommended daily dose of 500mg per day [VERIFIED]
- The clinically supported range where NAD+ increases are robust but the dose-response curve begins to flatten
Most adults will not need to exceed 500mg per day. The Yi et al. trial showed no statistically significant difference between 600mg and 900mg groups, and the Fukamizu safety study demonstrated that higher doses are tolerable but did not establish that they are more effective [VERIFIED].
When Higher Doses Might Be Considered
Some individuals — particularly those over 60, those with high physical demands, or those whose healthcare provider has recommended it — may benefit from 600–900mg daily. This should be a deliberate decision, not a default. More is not automatically better with NMN, and the cost per day increases proportionally.
When to Take NMN
Morning Is the Default Recommendation
NAD+ levels follow a circadian rhythm, peaking during your body's active daytime phase. Taking NMN in the morning aligns with this natural cycle and supports daytime energy production. Most clinical trials administered NMN in the morning or before noon.
For practical purposes: take your NMN capsule(s) first thing in the morning, either with breakfast or on an empty stomach. Both approaches are fine — NMN is well-absorbed orally regardless of food intake.
The Case for Evening Dosing (Older Adults)
The Kim et al. (2022) study split participants into morning and afternoon/evening dosing groups. Interestingly, the afternoon NMN group showed stronger improvements in physical performance (five-times sit-to-stand test) and greater reduction in daytime drowsiness compared to the morning group (Kim et al., 2022) [VERIFIED].
This suggests that for adults over 65, evening dosing may offer advantages — possibly because NAD+ supports overnight cellular repair processes that become increasingly important with age. However, this is a single study with a specific population. For most adults under 65, morning remains the standard recommendation.
Consistency Matters More Than Timing
Whichever time you choose, the most important factor is consistency. NMN works by gradually restoring NAD+ levels over days and weeks, not by producing an acute spike. Missing doses or alternating between morning and evening is more likely to reduce effectiveness than choosing the "wrong" time of day.
Can You Take Too Much NMN?
The short answer: no serious adverse events have been reported at any dose tested in human clinical trials, up to 1,250mg daily for four weeks (Fukamizu et al., 2022) [VERIFIED].
The longer answer: "safe" and "useful" are different questions. The Yi et al. (2023) data showed that NAD+ increases plateau around 600mg — the 900mg group did not achieve significantly higher NAD+ levels than the 600mg group [VERIFIED]. This suggests a ceiling effect: beyond a certain dose, your body's conversion capacity may be saturated, and additional NMN may not be efficiently converted to NAD+.
There is no established upper limit for NMN in any regulatory jurisdiction. Australia's TGA set the maximum recommended dose at 500mg per day for listed products, with a maximum recommended use period of 12 weeks [VERIFIED]. This is a regulatory guideline, not a toxicity threshold — but it is worth noting as the only formal regulatory benchmark that exists.
Practical guidance: Stay within 250–500mg daily unless your healthcare provider specifically recommends otherwise. There is no published evidence that exceeding 500mg produces better long-term outcomes in healthy adults.
NMN Side Effects
Across all published human clinical trials, NMN has demonstrated a reassuring safety profile. However, "reassuring" is not the same as "conclusive" — and understanding the limitations of the evidence is important.
What Clinical Trials Report
- A 2023 systematic review of NMN human trials concluded that NMN "did not trigger any adverse physiological effects" across all published randomised controlled trials (Song et al., 2023) [VERIFIED].
- Doses up to 1,250mg daily for four weeks showed no serious adverse events, no clinically significant changes in liver enzymes, kidney markers, or haematological parameters (Fukamizu et al., 2022) [VERIFIED].
- Across all dosage groups in the Yi et al. (2023) trial, adverse event rates were not statistically different from placebo [VERIFIED].
Mild Effects That Have Been Reported
When side effects do occur — and they are infrequent — they are typically mild and self-limiting:
- Mild stomach discomfort — usually during the first few days, often resolves within a week
- Headache — reported occasionally, not statistically different from placebo groups
- Skin flushing — rare, related to niacin metabolism (NMN is converted through pathways shared with vitamin B3)
- Mild nausea — uncommon, more likely on an empty stomach at higher doses
Who Should Be Cautious
- People on prescription medication: NMN may interact with drugs that affect NAD+ metabolism, including certain chemotherapy agents and immunosuppressants. Consult your prescribing doctor.
- Pregnant or breastfeeding women: No clinical trial data exists for this population. Avoid until safety is established.
- People with active cancer: NAD+ supports cellular energy and repair — which is generally desirable, but the theoretical concern is that it could also support rapidly dividing cells. This is unproven but warrants caution. Discuss with your oncologist.
- People with liver or kidney disease: While NMN trials have shown no negative effects on liver or kidney markers in healthy adults, individuals with existing organ impairment should consult their specialist.
The Honest Limitation
Most NMN trials have enrolled healthy adults, lasted 4–12 weeks, and involved modest sample sizes (30–108 participants). Long-term safety data beyond 12 weeks of daily use in humans is not yet available. The evidence is promising but early-stage. This is why starting at a lower dose and monitoring your response is more prudent than jumping to the maximum.
NMN and Other Supplements
NMN can be taken alongside most common supplements without known interactions. Here are the combinations that have the most scientific rationale:
NMN + Resveratrol
Resveratrol is a polyphenol that activates sirtuins — the proteins that use NAD+ for DNA repair and cellular maintenance. The theoretical logic: NMN provides the fuel (NAD+), and resveratrol activates the enzymes that use it. A 2022 preclinical study found that NMN combined with resveratrol increased NAD+ levels in heart tissue and muscle tissue compared to NMN alone (Bai et al., 2022) [VERIFIED]. Human clinical trial data on the combination specifically is still limited, but the mechanistic rationale is sound. Typical resveratrol doses in studies: 250–500mg daily.
NMN + TMG (Trimethylglycine)
When NMN raises NAD+ levels, NAD+-dependent reactions (particularly those involving sirtuins and PARPs) consume methyl groups. TMG is a methyl donor that helps replenish this supply. Some researchers, including David Sinclair of Harvard Medical School, have suggested pairing NMN with TMG to maintain methylation balance. Direct clinical trial evidence for the NMN + TMG combination is limited, but the biochemical rationale is well-established. Common TMG doses: 500–1,000mg daily.
NMN + Vitamin D
No direct interaction. Vitamin D and NMN operate through entirely different pathways. If you are supplementing with vitamin D (as many New Zealanders should — vitamin D insufficiency is common in NZ), there is no reason to stop when starting NMN.
What to Avoid
Avoid combining NMN with high-dose niacin (vitamin B3) without medical supervision, as both affect NAD+ metabolism through overlapping pathways and the cumulative effect on flushing and liver enzymes has not been studied in combination.
Frequently Asked Questions
How much NMN should I take per day?
For most adults, 250–500mg per day is the evidence-based range. Start at 250mg daily for two to four weeks, then increase to 500mg if well-tolerated. This aligns with multiple published clinical trials and Australia's TGA maximum recommended daily dose of 500mg per day [VERIFIED].
How long does it take for NMN to work?
Clinical trials show measurable increases in blood NAD+ levels within 14–30 days (Yi et al., 2023) [VERIFIED]. Subjective improvements in energy and physical performance are most commonly reported after 4–8 weeks of consistent daily use. NMN is not a supplement you will "feel" on day one — it works through gradual NAD+ restoration.
Should I take NMN on an empty stomach?
Either approach is fine. NMN is well-absorbed orally regardless of food intake. Some people report mild stomach discomfort when taking NMN on an empty stomach at higher doses (500mg+). If this occurs, taking it with breakfast typically resolves it.
Can I take NMN every day long-term?
There is no published evidence suggesting NMN needs to be cycled. However, the longest human trials are 12 weeks, so long-term daily use beyond that timeframe is based on extrapolation rather than direct data. Australia's TGA has set a maximum recommended use period of 12 weeks for listed products [VERIFIED]. If you plan to take NMN continuously, periodic check-ins with your healthcare provider are sensible.
Is 1,000mg of NMN too much?
Not necessarily unsafe — the Fukamizu et al. (2022) trial tested 1,250mg daily with no serious adverse events [VERIFIED]. However, the Yi et al. (2023) data suggests that benefits plateau around 600mg, meaning 1,000mg is likely safe but probably not more effective than 500–600mg for most people [VERIFIED]. Higher doses also increase cost without proportional benefit.
What is the difference between NMN and NR?
NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are both NAD+ precursors. NMN has an additional phosphate group and is one step closer to NAD+ in the biosynthetic pathway. Both raise NAD+ levels effectively. NR has more long-term human safety data (up to two years in some studies), while NMN has more recent dose-ranging clinical trials. For a deeper comparison, see our NMN Buyer's Guide.
Does NMN interact with medications?
No harmful interactions have been documented in published clinical trials. However, NMN affects NAD+ metabolism, which overlaps with pathways used by certain medications — particularly some chemotherapy agents, immunosuppressants, and drugs metabolised by the liver. If you take prescription medication, consult your pharmacist or doctor before starting NMN.
How WIIP NMN Boost Fits This Dosage Framework
We selected and developed WIIP NMN Boost around the evidence outlined in this article. Each capsule contains 250mg of NMN — aligned with the evidence-based starting dose shown effective in the Kim (2022) and Igarashi (2022) trials. Two capsules per serve deliver 500mg per two-capsule serve — the maintenance dose supported by the Yi et al. (2023) data and aligned with TGA guidelines. Sixty capsules per bottle gives you a full 30-day supply at the 500mg maintenance dose.
NZ-made and clinician-developed. No proprietary blends, no hidden ingredients, no therapeutic claims.
If you are trying NMN for the first time, start with one capsule (250mg) daily. After two to four weeks, move to two capsules (500mg) if you are tolerating it well. That is exactly the protocol the clinical evidence supports.
View WIIP NMN Boost — $94.99, 60 Capsules (250mg each), 500mg Per Two-Capsule Serve
Related Reading
- NMN Supplement NZ: Complete Buyer's Guide — Purity, regulation, what to look for when buying NMN in New Zealand
- Best NMN Supplements NZ — 2026 Comparison — Side-by-side product comparison with pricing and testing data
Sources
- Yi, L. et al. (2023). "The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial." GeroScience. DOI
- Kim, M. et al. (2022). "Effect of 12-Week Intake of Nicotinamide Mononucleotide on Sleep Quality, Fatigue, and Physical Performance in Older Japanese Adults: A Randomized, Double-Blind Placebo-Controlled Study." Nutrients. PMC8877443
- Igarashi, M. et al. (2022). "Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men." NPJ Aging. PubMed: 35927255
- Fukamizu, Y. et al. (2022). "Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women." Scientific Reports. DOI
- Song, Q. et al. (2023). "The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update." Advances in Nutrition. PMC10721522
- Bai, L.B. et al. (2022). "Improvement of tissue-specific distribution and biotransformation potential of nicotinamide mononucleotide in combination with ginsenosides or resveratrol." Pharmacology Research & Perspectives (2022;10(4):e00986). PMC9289528
- NutraIngredients (Dec 2025). "Australia's TGA approves NMN ingredient for supplement use." Link
Dr. Jun is a Senior Chiropractor at Auckland Wellness Centre with 12 years of clinical experience. He holds qualifications from the New Zealand College of Chiropractic (NZCC) and is certified in Titleist Performance Institute (TPI) assessment and Active Release Techniques (ART). Dr. Jun selected and developed WIIP supplements based on clinical experience and published research, with a focus on evidence-based dosing and transparent labelling.
This article is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any new supplement. NMN supplements are not intended to treat, cure, or prevent any disease.